President Trump’s steel and aluminum tariffs may not result in the intended boom for the U.S. steel industry.
“If the automakers are using less metal, they’re selling less product because of these tariffs, eventually I think it’s going to hurt steel stocks,” said Patrick Sanders, Assistant Managing Editor at U.S. News & World Report.
He pointed out that Bank of America has already downgraded U.S. Steel in light of Trump’s announcement.
The tariffs could also hit employment numbers, said Sanders.
“The last time that we had steel tariffs was in 2003. About 200,000 people lost their jobs. A lot of those were in the auto industry.”
On Thursday, Trump stated he’d slap a 25 percent tax on steel imports and a 10 percent tarriff on aluminum imported into the U.S.
Trump claimed the policy would benefit American industrials, tweeting, “We must protect our country and our workers. Our steel industry is in bad shape.”
Some House Democrats will have to vote for McCarthy's bill if enough conservative Republicans keep their word to oppose any compromise.
Blue Bird, a maker of school buses, opened up a production facility to meet the rising demand for electric school buses.
The National Eating Disorders Association said it's replacing its staff with an artificial intelligence chatbot.
Hyundai and LG announced a partnership to build a $4.3 billion electric battery plant in Georgia.
JPMorgan announced job cuts at First Republic Bank, a month after acquiring the company.
AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
The federal government is giving away for free some historic lighthouses and is also auctioning some of them off too.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Elon Musk's brain-implant company Neuralink said it received approval from the Food and Drug Administration to begin human clinical trials.
Aileen Del Cid, head of marketing at Samsung TV Plus, sat down with Cheddar News reporter Michelle Castillo to discuss the platform's plans to stand out from the streaming competition with a new channel featuring Conan O'Brien.
Load More